Institute for Immunodeficiency (IFI)
Center for Chronic Immunodeficiency (CCI)
Medical Center – University of Freiburg
Breisacher Str. 115
D-79106 Freiburg
- +49 (0)761 270-71080
- anne.rensing-ehl@uniklinik-freiburg.de
- Homepage
Current position
Group leader, Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center – University of Freiburg
Academic training
| 1985 - 1992 | Study of Medicine in Aachen, Erlangen and Munich |
Scientific qualifications
| 1992 | Dissertation in Medicine, University of Erlangen (Supervisor: Prof. Dr. G. Burmester) |
Postgraduate Positions
| since 2022 | Group leader, Institute for Immunodeficiency, Medical Center – University of Freiburg |
| 2008 - 2022 | Postdoctorate in part time, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg |
| 2005 - 2008 | Postdoctorate in part time, Department of Dermatology, University of Freiburg |
| 1994 - 1995 | Postdoctorate, Institute for Clinical Immunology, University of Zurich, Switzerland |
| 1993 - 1994 | Postdoctorate, Institute for Immunology, University of Munich |
link to all publications from A. Rensing-Ehl: Pubmed
Publications based on CRC1160 funding
Hägele P, Staus P, Scheible R, Uhlmann A, Heeg M, Klemann C, Maccari ME, Ritterbusch H, Armstrong M, Cutcutache I, Elliott KS, von Bernuth H, Leahy TR, Leyh J, Holzinger D, Lehmberg K, Svec P, Masjosthusmann K, Hambleton S, Jakob M, Sparber-Sauer M, Kager L, Puzik A, Wolkewitz M, Lorenz MR, Schwarz K, Speckmann C, Rensing-Ehl A, Ehl S; ALPID study group. 2024. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study. Lancet Haematol. 11(2):e114-e126. doi: 10.1016/S2352-3026(23)00362-9.
Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, Bakardjieva M, Stancikova J, Raabe J, Neumann J, Schwenk S, Arpesella L, Stuchly J, Benes V, García Valiente R, Fernández García J, Carsetti R, Piano Mortari E, Catala A, de la Calle O, Sogkas G, Neven B, Rieux-Laucat F, Magerus A, Neth O, Olbrich P, Voll RE, Alsina L, Allende LM, Gonzalez-Granado LI, Böhler C, Thiel J, Venhoff N, Lorenzetti R, Warnatz K, Unger S, Seidl M, Mielenz D, Schneider P, Ehl S, Rensing-Ehl A, Smulski CR, Rizzi M. 2024. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells. Sci Immunol. Jan 12;9(91):eadj5948. doi: 10.1126/sciimmunol.adj5948.
Rensing-Ehl, A., M. R. Lorenz, M. Fuhrer, W. Willenbacher, E. Willenbacher, S. Sopper, M. Abinun, M. E. Maccari, C. Konig, P. Haegele, S. Fuchs, C. Castro, P. Kury, O. Pelle, C. Klemann, M. Heeg, J. Thalhammer, O. Wegehaupt, M. Fischer, S. Goldacker, B. Schulte, S. Biskup, P. Chatelain, V. Schuster, K. Warnatz, B. Grimbacher, A. Meinhardt, D. Holzinger, P. T. Oommen, T. Hinze, H. Hebart, K. Seeger, K. Lehmberg, T. R. Leahy, A. Claviez, S. Vieth, F. H. Schilling, I. Fuchs, M. Gross, F. Rieux-Laucat, A. Magerus, C. Speckmann, K. Schwarz, S. Ehl, and A. s. group. 2023. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing. J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.11.006.
Magerus, A., A. Rensing-Ehl, V. K. Rao, D. Teachey, F. Rieux-Laucat, and S. Ehl. 2023. Autoimmune-lymphoproliferative immunodeficiencies (ALPID) A proposed approach to redefining ALPS and other lymphoproliferative immune disorders. J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.11.004.
Cox EM, El-Behi M, Ries S, Vogt JF, Kohlhaas V, Michna T, Manfroi B, Al-Maarri M, Wanke F, Tirosh B, Pondarre C, Lezeau H, Yogev N, Mittenzwei R, Descatoire M, Weller S, Weill JC, Reynaud CA, Boudinot P, Jouneau L, Tenzer S, Distler U, Rensing-Ehl A, König C, Staniek J, Rizzi M, Magérus A, Rieux-Laucat F, Wunderlich FT, Hövelmeyer N, Fillatreau S. 2023. AKT activity orchestrates marginal zone B cell development in mice and humans. Cell Rep. 2023 Apr 14;42(4):112378. doi: 10.1016/j.celrep.2023.112378.
